DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
Findings from a retrospective cohort study conducted at a single hospital suggest that patients with sickle cell disease have a lower — and not higher — risk for Clostridioides difficile infection compared with the hospitalwide patient population, researchers reported in The New England Journal of Medicine.
In introducing their study, Seah H. Lim, MD, PhD, and colleagues from New York Medical College said health care-associated C. difficile infections “might be expected to be more common” in patients with sickle cell disease, and not less common, as the study found.
“Patients with sickle cell disease have defects in immune function; they are frequently hospitalized for painful vaso-occlusive crisis and are often given empirical antibiotic treatment for fever in this setting. They also have intestinal dysbiosis,” they wrote.
people & placesLifespan Comprehensive Sickle Cell CenterThe Lifespan Comprehensive Sickle Cell C...
people & placesSt. Louis Children’s HospitalThe St. Louis Children's Hospital Sickle...
news & eventsRandomized Trials Needed to Assess Benefits of Salmonella Vaccines in SCD Patients, Study SaysRandomized controlled trials are needed ...
education & researchSickle Cell Disease Tips for Healthy LivingCommon illnesses, like the flu, can quic...
news & eventsSCA Therapy Hydroxyurea Doesn’t Boost Malaria Risk in Sub-Saharan Africa, Study FindsHydroxyurea, a treatment recommended for...
education & researchManagement of infections in SCD patients treated with HU in the framework of Escort HUBackground and method: This study aims t...
news & eventsShakir Cannon, advocate for minority health, diesShakir Lateef Cannon, a 34-year-old advo...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.